Previous studies have found that PRDX2 protein levels were higher in human CRC tissues and were closely correlated with CRC progression, suggesting the potential of targeting PRDX2 for the clinic treatment of CRC 43. The gene discussed is PRDX2; the disease is colorectal carcinoma.